09 Mar 2020
The Food and Drug Administration has approved a new oral treatment that reduces cortisol production for patients with Cushing’s disease.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024